Jw. Unger et al., NERVE GROWTH-FACTOR (NGF) AND DIABETIC NEUROPATHY IN THE RAT - MORPHOLOGICAL INVESTIGATIONS OF THE SURAL NERVE, DORSAL-ROOT GANGLION, AND SPINAL-CORD, Experimental neurology, 153(1), 1998, pp. 23-34
A number of functions for nerve growth factor (NGF) have been describe
d over the past years, including its role for neuronal function and re
generation during toxic or metabolic neuropathies. In order to further
assess the effects of NGF on the somatosensory system in diabetic neu
ropathy, the sural nerve, dorsal root ganglia (DRG), and dorsal horn o
f the spinal cord were investigated by morphological and quantitative
methods in rats after 12 weeks of uncontrolled streptozotocin-induced
diabetes mellitus. The results from our study suggest a twofold effect
of NGF: (1) In sural nerve treatment with NGF (0.1 or 0.5 mg/kg) for
12 weeks was able to reverse distinct diabetes-related alterations in
myelinated nerve fiber morphology, such as myelin thickness. These cha
nges occured in the entire myelinated population of sensory nerves and
were not restricted to nociceptive nerve fibers. (2) The NGF effect o
n neurotransmitters of the sensory, nociceptive system was reflected b
y increased CG;RP and substance P content in the DRG and in the dorsal
horn of the spinal cord. No change of trkA receptor immunostaining wa
s seen in DRGs of diabetic rats; however, a reduction of trkA immunore
activity of DRG neurons was noted after long-term NGF treatment of hea
lthy controls. The data demonstrate that NGF regulates a number of neu
ronal parameters along peripheral and central parts of the somatosenso
ry pathway in the adult. This neurotrophic support may be essential fo
r inducing functionally significant regenerative mechanisms in diabeti
c neuropathy. (C) 1998 Academic Press.